Drug class
Tetanus Immune Globulin
Tetanus immune globulin is a hyperimmune biologic agent prepared from human plasma containing high titers of antibodies against the exotoxin produced by *Clostridium tetani*. Read more about Tetanus Immune Globulin
3 drugs in this class 1 manufacturers
Drugs in Tetanus Immune Globulin
HYPERTET (PF) (tetanus immune globulin/PF)
HYPERTET (tetanus immune globulin/PF)
Tetanus immune globulin is a hyperimmune biologic agent prepared from human plasma containing high titers of antibodies against the exotoxin produced by *Clostridium tetani*.
It confers immediate, temporary passive immunity by binding and neutralizing free, circulating tetanus toxin before it can attach to nerve terminals in the central nervous system.
Clinically, it is primarily indicated for post-exposure prophylaxis following acute, tetanus-prone wounds in individuals with an incomplete or uncertain immunization status, and it is also used as part of the regimen for managing active clinical tetanus.
-
fda.gov
Tetanus immune globulin is a hyperimmune biologic agent prepared from human plasma containing high titers of antibodies against the exotoxin produced by *Clostridium tetani* Clinically, it is primarily indicated for post-exposure prophylaxis following acute, tetanus-prone wounds in individuals with an incomplete or uncertain immunization status, and it is also used as part of the regimen for managing active clinical tetanus
-
fda.gov
Tetanus immune globulin is a hyperimmune biologic agent prepared from human plasma containing high titers of antibodies against the exotoxin produced by *Clostridium tetani*
-
hypertet.com
Tetanus immune globulin is a hyperimmune biologic agent prepared from human plasma containing high titers of antibodies against the exotoxin produced by *Clostridium tetani* Clinically, it is primarily indicated for post-exposure prophylaxis following acute, tetanus-prone wounds in individuals with an incomplete or uncertain immunization status, and it is also used as part of the regimen for managing active clinical tetanus
-
cdc.gov
It confers immediate, temporary passive immunity by binding and neutralizing free, circulating tetanus toxin before it can attach to nerve terminals in the central nervous system Clinically, it is primarily indicated for post-exposure prophylaxis following acute, tetanus-prone wounds in individuals with an incomplete or uncertain immunization status, and it is also used as part of the regimen for managing active clinical tetanus
-
pharmacyjoe.com
It confers immediate, temporary passive immunity by binding and neutralizing free, circulating tetanus toxin before it can attach to nerve terminals in the central nervous system
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.